CAJ | 학술논문

目的：探讨疏血通治疗肺纤维化的临床疗效。方法选择在我院治疗的肺纤维化患者60例为研究对象，其中30例采用强的松治疗为对照组，30例在强的松治疗基础上予疏血通治疗为研究组；比较两组患者治疗前后肺功能、动脉血气、肺部CT等结果。结果研究组显效率显著高于对照组（P<0.01）。研究组治疗后FEV1较治疗前显著提高，且显著高于对照组（P均约0.05）；研究组治疗后PaO2水平较治疗前显著升高，且高于对照组（P<0.05）。结论轻度、中度肺纤维化患者在常规治疗的基础上予疏血通治疗能够显著改善患者的临床疗效及肺功能。
목적：탐토소혈통치료폐섬유화적림상료효。방법선택재아원치료적폐섬유화환자60례위연구대상，기중30례채용강적송치료위대조조，30례재강적송치료기출상여소혈통치료위연구조；비교량조환자치료전후폐공능、동맥혈기、폐부CT등결과。결과연구조현효솔현저고우대조조（P<0.01）。연구조치료후FEV1교치료전현저제고，차현저고우대조조（P균약0.05）；연구조치료후PaO2수평교치료전현저승고，차고우대조조（P<0.05）。결론경도、중도폐섬유화환자재상규치료적기출상여소혈통치료능구현저개선환자적림상료효급폐공능。
Objective To discuss clinical efficacy of shuxuetong in treatment of pulmonary fibrosis. Methods Selected 60 cases with pulmonary fibrosis and they were divided into control group of 30 cases treated by prednisone and study group of 30 cases treated by shuxuetong based on treatment of prednisone. Lung function, arterial blood gas and lung CT were compared. Results The efficiency of study group was higher than control group (P<0.01). FEV1 of study group after treatment was higher than before treatment, and was higher than control group after treatment(P all<0.05). PaO2 of study group after treatment improved apparently, and was higher than control group (P<0.05). Conclusion Clinical effi-cacy and lung function of mild, moderate pulmonary fibrosis patients are improved with treatment of shuxuetong based on prednisone.